Skip to content

Clinical trials

Hypertension trials in Brazil with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Not applicable Country / region: Brazil Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20082
20094
20105
20112
20123
20134
201411
20156
20162
20179
20188
201916
20204
20214
20227
20234
20249
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Unknown status22
Recruiting15
Terminated4
Active, not recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital de Clinicas de Porto Alegre15
Instituto de Cardiologia do Rio Grande do Sul11
Federal University of Uberlandia7
Universidade Federal de Santa Catarina5
University of Sao Paulo5
Federal University of São Paulo4
Hospital Israelita Albert Einstein4
Universidade Federal Fluminense4
University of Sao Paulo General Hospital4
Federal University of Bahia3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension112
Diabetes Mellitus11
Cardiovascular Diseases9
Obesity6
Dyslipidemias4
Hypertension, Pregnancy-Induced4
Sleep Apnea, Obstructive4
Diabetes Mellitus, Type 23
Inflammation3
Post-Exercise Hypotension3

Trials

Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.